Document is current
Any future updates will be listed below
-
Authors
Jacobs, Jonathan P.
Lagishetty, Venu
Hauer, Megan C.
Labus, Jennifer S.
Dong, Tien S.
Toma, Ryan
Vuyisich, Momchilo
Naliboff, Bruce D.
Lackner, Jeffrey M.
Gupta, Arpana
Tillisch, Kirsten
Mayer, Emeran A.
- License Information
-
More Information
Article History
Received: 23 March 2022
Accepted: 14 December 2022
First Online: 10 January 2023
Declarations
:
: Institutional Review Boards at each of two sites approved the protocols governing participants: UCLA (IRB#11-000069, IRB#11-002818, IRB#12-001802, IRB#14-000333, IRB#15-001591, IRB#16-000187) and University at Buffalo (IRB#030-745083). All subjects provided informed consent to participate.
: Not applicable.
: EAM is a scientific advisory board member of Danone, Axial Biotherapeutics, Amare, Mahana Therapeutics, Pendulum, Bloom Biosciences, Seed, and APC Microbiome Ireland. RT and MV are employees of Viome Life Sciences. JPJ, VL, MH, JSL, TSD, BDN, JML, AG, and KT do not have any disclosures.
